10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,106 | -26.1% | 9,045 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $505,073 | -14.8% | 9,045 | -14.9% | 0.00% | 0.0% |
| Q1 2023 | $593,103 | -36.9% | 10,631 | -58.8% | 0.00% | -66.7% |
| Q4 2022 | $939,350 | -86.7% | 25,778 | -89.6% | 0.00% | -85.7% |
| Q3 2022 | $7,050,000 | +40.0% | 247,528 | +122.5% | 0.02% | +50.0% |
| Q2 2022 | $5,034,000 | +251600.0% | 111,233 | +347503.1% | 0.01% | – |
| Q1 2022 | $2,000 | -100.0% | 32 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $7,174,000 | +473.0% | 50,662 | +404.4% | 0.02% | +400.0% |
| Q3 2020 | $1,252,000 | – | 10,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |